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Background: No study has been carried out on the time trend in the prevalence of chronic bronchitis (CB) in
recent years, despite its clinical and epidemiological relevance. We evaluated the trend in CB prevalence during the
past decade among young Italian adults.
Methods: A screening questionnaire was mailed to general population samples of 20–44 year-old subjects in two
cross-sectional surveys: the Italian Study on Asthma in Young Adults (ISAYA) (1998/2000; n = 18,873, 9 centres) and
the screening stage of the Gene Environment Interactions in Respiratory Diseases (GEIRD) study (2007/2010; n =
10,494, 7 centres). CB was defined as having cough and phlegm on most days for a minimum of 3 months a year
and for at least 2 successive years. The prevalence rates and the risk ratios (RRs) for the association between CB and
each potential predictor were adjusted for gender, age, season of response, type of contact, cumulative response
rate, and centre.
Results: CB prevalence was 12.5% (95% CI: 12.1-12.9%) in 1998/2000 and 12.6% (95% CI: 11.7-13.7%) in 2007/2010; it
increased among never smokers (from 7.6 to 9.1%, p = 0.003), current light smokers (<15 pack-years; from 15.1 to
18.6%, p < 0.001), and unemployed/retired subjects (from 14.3 to 19.1%, p = 0.001). In this decade, the prevalence of
current smoking decreased (from 33.6 to 26.9%, p < 0.001), whereas the prevalence of unemployment/premature
retirement (from 5.3 to 6.0%, p = 0.005), asthma (from 5.0 to 6.2%, p = 0.003), and allergic rhinitis (from 19.5 to
24.5%, p < 0.001) increased. In both 1998/2000 and 2007/2010, the likelihood of having CB was significantly higher
for women, current smokers, asthmatic patients, and subjects with allergic rhinitis. During this period, the strength
of the association between CB and current heavy smoking (≥15 pack-years) decreased (RR: from 4.82 to 3.57, p =
0.018), whereas it increased for unemployment/premature retirement (from 1.11 to 1.53, p = 0.019); no change was
observed for gender, asthma, and allergic rhinitis.
Conclusions: Despite the significant reduction in current smoking, CB prevalence did not vary among young Italian
adults. The temporal pattern of CB prevalence can only be partly explained by the increase of unemployment/
premature retirement, asthma and allergic rhinitis, and suggests that other factors could have played a role.
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Chronic bronchitis (CB) (i.e. a mucus-producing cough
on most days for a minimum of 3 months a year and for
at least 2 consecutive years) is a highly prevalent respira-
tory disorder, usually associated with cigarette smoking
[1,2]. CB can precede the development of chronic ob-
structive pulmonary disease (COPD) [3,4], and it
increases the likelihood of exacerbations, hospitalization,
and mortality in COPD patients [5-7]. Passive smoking,
air pollution, and occupational exposures to dust, gas,
and fumes can also increase the risk of CB [8-10]. Fur-
thermore, CB may be associated with asthma and may
be a marker of both asthma severity [11] and poor con-
trol of symptoms [12], which in turn are associated with
a heavy socio-economic burden [13-15]. CB in asthmatic
subjects may also indicate the presence of the asthma-
COPD overlap syndrome, which is a difficult condition
to treat [16]. In addition, CB can be related to allergic
rhinitis and gastroesophageal reflux disease (GORD)
[17,18].
While the prevalence of asthma and allergic rhinitis
increased during the last decade in Italy [19], so far no
study has been carried out on the time trend in the
prevalence of CB in recent years, despite its clinical and
epidemiological relevance. Accordingly, the present
study is aimed at evaluating the ten-year trend in the
prevalence of CB among young adults (20–44 years) in
Italy, and at evaluating whether the pattern of the associ-
ation with potential predictors changed during the last
decade. To fulfil these objectives, we used the data from
two cross-sectional surveys, the Italian Study on Asthma
in Young Adults (ISAYA) [20] and the screening stage of
the Gene Environment Interactions in Respiratory Dis-
eases (GEIRD) study [21].
Methods
Design of the study and definitions
ISAYA and GEIRD-screening stage were two cross-
sectional surveys on respiratory health in the general
adult population, which were carried out in Italy be-
tween 1998–2000 and between 2007–2010, respectively.
ISAYA involved 25,969 subjects from 9 centres (Ferrara,
Pavia, Pisa, Sassari, Sassuolo, Siracusa, Turin, Udine,
Verona) with an overall response rate of 72.7% [20],
whereas GEIRD involved 18,357 subjects from 7 centres
(Ancona, Pavia, Salerno, Sassari, Terni, Turin, Verona)
with an overall response rate of 57.2% [19]. In both the
studies, random samples of 3,000 subjects aged 20–44
(men/women ratio = 1) were selected in each centre
from the general population, using the local health au-
thority registers. A screening questionnaire [21,22] was
mailed to each subject up to three times and then admi-
nistered by telephone in case of non response. Ethics ap-
proval was obtained in each centre involved in GEIRDfrom the appropriate ethics committee (Comitato Etico
dell’Azienda Ospedaliero-Universitaria Ospedali Riuniti
di Ancona; Comitato di Bioetica della Fondazione IRCCS
Policlinico San Matteo di Pavia; Comitato Etico dell’A-
zienda Sanitaria Locale SA/2 di Salerno; Comitato di
Bioetica dell’Azienda Sanitaria Locale di Sassari; Comi-
tato Etico delle Aziende Sanitarie dell'Umbria di Perugia;
Comitato Etico dell’Azienda Sanitaria Locale TO/2 di
Torino; Comitato Etico per la Sperimentazione dell'Azienda
Ospedaliera Istituti Ospitalieri di Verona). All partici-
pants were fully informed about all aspects of the re-
search project and consented to complete and return
the questionnaire.
The screening questionnaires used in ISAYA and
GEIRD shared a set of core questions (mainly taken
from the European Community Respiratory Health Sur-
vey [ECRHS] questionnaires [23]) on the presence of
asthma (self-report of the disease during lifetime with or
without a physician diagnosis, frequency of asthma
attacks and use of anti-asthmatic drugs in the last 12
months), asthma-like symptoms (wheezing, nocturnal
tightness in the chest, and attacks of shortness of breath
at night time in the last 12 months), allergic rhinitis (any
nasal allergies, including hay fever), and CB (cough and
phlegm on most days for a minimum of 3 months a year
and for at least 2 successive years), as well as questions
on smoking habits (the age of smoking commencement,
the amount of tobacco smoked, and the age at which
smokers stopped smoking). The screening questionnaire
used in GEIRD also contained questions on the fre-
quency of vehicular traffic (cars and trucks) near home.
Smoking habits were classified as current light/heavy
smoking, past light/heavy smoking, or never smoking
according to lifetime pack-years, considering 15 pack-
years as the cut-off. Ever smoking was defined as having
smoked at least one cigarette per day or one cigar a
week for one year. Asthma was considered present if a
subject had reported asthma confirmed by a doctor and
at least one respiratory symptom (wheezing, nocturnal
tightness in the chest, attacks of shortness of breath at
night time) or at least one attack of asthma or use of
medicines because of breathing problems in the last 12
months.
Statistical analysis
The data from all the centres that participated in ISAYA
and/or GEIRD were used in the analysis. Gender, age,
season of response, type of contact, and cumulative re-
sponse rate were considered as potential confounders
because of differences in their distribution between the
two surveys (Table 1). In particular, the cumulative re-
sponse percentile rank was used: each subject was
ordered by study and centre according to the date of re-
sponse to the questionnaire, and then he/she was
Table 1 Distribution of the design variables
ISAYA (1998/2000) N = 25,969 GEIRD (2007/2010) N = 18,357 p-value*
N° of responders (response rate, %) 18,873 (72.7) 10,494 (57.2) <0.001
Season at time of the interview, % <0.001
spring 18.5 41.0
summer 16.4 22.1
autumn 40.4 25.7
winter 24.7 11.2
Phone contact, % 27.9 11.8 <0.001
Females, % 50.7 52.3 0.008
Age (years), mean (sd) 33.1 (6.9) 34.7 (7.1) <0.001
* p-value obtained by Pearson’s chi-squared test and two-sample t test with unequal variances.
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ber of eligible subjects [19].
Adjusted prevalence rates of CB were computed by lo-
gistic regression models. The models had an indicator of
the presence of CB as the dependent variable and the
study (GEIRD vs ISAYA), the potential confounders
reported above, and centre as covariates. Centre was
included in the models in order to partly control for the
potential confounding effect of ecological-level variables,
such as environmental factors. Since the subjects were
nested into groups (the study -ISAYA or GEIRD- in
which they participated, crossed by centre), clustered
sandwich estimators of the variance were used. The
prevalence rates in each survey were estimated by setting
the distribution of gender, season of response, type of
contact, and centre equal to the average distribution,
and by setting age and the cumulative response rate
equal to the overall mean [24], in order to make the
ISAYA and GEIRD estimates comparable.
The association between gender, smoking habits, occu-
pational status, asthma, allergic rhinitis, and the pres-
ence of CB was estimated by the risk ratios (RRs),
separately for each survey. The RRs were computed by
Poisson regression models with robust standard errors
(obtained by the Huber/White/sandwich estimator of
the variance) and no offset [25], and were adjusted for
the potential confounding effect of the same variables as
the prevalence rates. The RRs were also computed by in-
cluding a dummy variable for the high frequency of ve-
hicular traffic (i.e. a continuous passage of cars and/or
trucks) near home in the GEIRD model.
The statistical analysis was performed using STATA
software, release 12 (StataCorp, College Station, TX).
Results
Ten-year trend in the prevalence of CB
The prevalence of CB was 12.5% (95%CI: 12.1-12.9%) in
1998/2000 and 12.6% (95%CI: 11.7-13.7%) ten years
later, and it did not significantly vary according togender and age (Table 2). A statistically significant trend
in the prevalence of CB was observed among never smo-
kers (from 7.6 to 9.1%, p = 0.003) and current light smo-
kers (<15 pack-years: from 15.1 to 18.6%, p < 0.001), but
not among current heavy smokers (≥15 pack-years) and
past smokers (Figure 1). According to occupational sta-
tus, the prevalence of CB significantly increased among
unemployed/retired subjects (from 14.3 to 19.1%, p =
0.001), but not among employed subjects/house-per-
sons/students (from 12.3 to 12.1%, p = 0.764).
Ten-year trend in the distribution of smoking habits,
occupational status, asthma, and allergic rhinitis
During this period, there was a statistically significant
decrease in the percentage of current smokers (from
33.6 to 26.9%, p < 0.001) and in the percentage of
current smokers according to the amount of exposure
(current light smokers: from 22.5 to 19.8%, p < 0.001;
current heavy smokers: from 7.0 to 4.2%, p < 0.001)
(Table 3). Moreover, a statistically significant change was
observed in the percentage of past heavy smokers (from
1.2 to 0.8%, p < 0.001), but not in the percentage of past
light smokers. In addition, a statistically significant in-
crease was observed in the percentage of unemployed/
retired individuals (from 5.3 to 6.0%, p = 0.005), asth-
matic patients (from 5.0 to 6.2%, p = 0.003), and subjects
with allergic rhinitis (from 19.5 to 24.5%, p < 0.001). In
the same decade, there was no statistically significant
change in the percentage of asthmatic patients who also
reported CB, and in the percentage of subjects with al-
lergic rhinitis and coexisting CB (Table 4).
Changes in the pattern of the association between the
presence of CB and the potential predictors
In both 1998/2000 and 2007/2010, the likelihood of hav-
ing CB was significantly higher for women, current smo-
kers and past heavy smokers (as compared to never
smokers), asthmatic patients, and subjects with allergic
rhinitis (Table 5). During this ten-year period, the
Table 2 Adjusted prevalence of CB according to gender and age
Adjusted prevalence (%) [95% CI]
ISAYA (1998/2000) GEIRD (2007/2010) p-value‡
Gender* Males 12.3 [12.0−12.6] 12.6 [11.8−13.4] 0.575
Females 12.6 [11.9−13.3] 12.7 [11.3−14.3] 0.920
Age† <30 years 11.8 [11.2−12.5] 12.2 [10.9−13.6] 0.577
≥30 years 12.7 [12.2−13.2] 12.9 [12.0−13.8] 0.692
TOTAL¶ 12.5 [12.1−12.9] 12.6 [11.7−13.7] 0.781
* prevalence obtained by stratifying on gender and adjusted for age, season of response, type of contact, cumulative response rate, and centre.
† prevalence obtained by stratifying on age and adjusted for gender, season of response, type of contact, cumulative response rate, and centre.
¶ prevalence adjusted for gender, age, season of response, type of contact, cumulative response rate, and centre.
‡ p-value obtained by testing the null hypothesis that the regression coefficient of the dummy indicator of the study (GEIRD vs ISAYA) was zero.
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the presence of CB decreased (with a dissimilar change
in the RRs according to pack-years for both past and
current smoking), whereas the strength of the associ-
ation increased for unemployment/premature retire-
ment. No change in the RRs was observed for gender,
asthma, and allergic rhinitis. When the high frequency
of vehicular traffic near home was also considered in the
GEIRD model (2007/2010), traffic-related air pollution
was significantly associated with the presence of CB (RR
= 1.27; 95%CI: 1.14-1.41).Sensitivity analysis
These results were confirmed when only the data from
the four centres (Pavia, Sassari, Turin, Verona) that had
participated in both the surveys were considered in the
analysis. In particular, the prevalence of CB was 12.4% in
1998/2000 and 12.5% in 2007/2010, and the estimates of
the RRs were comparable to those obtained in the main
analysis (an additional table shows this in more detail
[see Additional file 1]).Discussion
The main results of the present study are the following:0
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Figure 1 Adjusted prevalence of CB according to smoking
habits. Bars represent 95% confidence intervals.• the prevalence of CB did not vary during the past
decade among young adults in Italy, despite a 7%
reduction in the percentage of current smokers;
• the increase in the prevalence of CB among never
smokers and the decrease in the strength of the
association between current smoking and CB observed
in the last ten years, suggest that factors other than
smoking could have played a major role in determining
the trend in the prevalence of CB;
• CB is common in asthmatic patients and in subjects
with allergic rhinitis, and its association with these
respiratory diseases has not changed with time.
The prevalence of CB did not change in the past decade,
despite the striking reduction in the percentage of
current smokers
The prevalence rates of CB among 20–44 year-old sub-
jects remained stable during the past ten years in Italy
and were similar to that reported in the three Italian
centres (Pavia, Turin, Verona) that had participated in
the ECRHS in 1991/1993 (median prevalence: 11.3%)
[17]. Moreover, the estimates from ISAYA and GEIRD
are comparable to that obtained for the same age class
in 16 industrialized countries in the ECRHS (10.2%)
[17]. The impressive prevalence rates of CB estimated
from the ISAYA and GEIRD studies enlighten the fact
that CB is a substantial health problem even in young
adults. Although CB may not lead to COPD in many of
these subjects, our estimates suggest that the base of the
COPD iceberg was wide and did not decrease during the
past decade in Italy [2].
It could be surprising that there was no significant de-
crease in the prevalence of CB during the past decades
in view of the fact that the percentage of current smo-
kers decreased in Italy during the last twenty years [26],
as also documented in our study. In fact, the relationship
between smoking and CB is well known, and the amount
of tobacco smoke determines the frequency and severity
of symptoms [2,27]. Accordingly, we found that smoking
habits is the strongest predictor of the presence of CB,
since the RRs were the highest for current smoking. In
Table 3 Adjusted percentage* of past/current smokers, unemployed/retired subjects, subjects with asthma, and
subjects with allergic rhinitis
Adjusted % [95% CI]
ISAYA (1998/2000) GEIRD (2007/2010) p-value†
Past light smokers 11.2 [10.9−11.6] 11.7 [11.1−12.2] 0.219
Past heavy smokers 1.2 [1.1−1.3] 0.8 [0.7−1.0] <0.001
Current light smokers 22.5 [22.0−23.1] 19.8 [18.9−20.7] <0.001
Current heavy smokers 7.0 [6.7−7.4] 4.2 [3.8−4.6] <0.001
Unemployed/retired subjects 5.3 [5.1−5.6] 6.0 [5.7−6.3] 0.005
Subjects with asthma 5.0 [4.7−5.3] 6.2 [5.6−6.8] 0.003
Subjects with allergic rhinitis 19.5 [19.2−19.9] 24.5 [23.8−25.2] <0.001
* adjusted for gender, age, season of response, type of contact, cumulative response rate, and centre.
† p-value obtained by testing the null hypothesis that the regression coefficient of the dummy indicator of the study (GEIRD vs ISAYA) was zero.
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according to the amount of past and current active ex-
posure. However, the prevalence of CB significantly
increased among never smokers during the past decade,
resulting in a reduction of the strength of the association
between CB and smoking. Hence, our findings add to
the emerging evidence that factors other than smoking
play a major role in respiratory diseases [28].
Temporal variation in the association between the
presence of CB and other factors
The risk of having CB among unemployed/retired sub-
jects significantly increased during the past decade. Un-
employment/premature retirement can be considered a
proxy measure for socio-economic status. Socio-
economically disadvantaged subjects might be more sus-
ceptible to respiratory infections, such as pertussis,
repeated viral infections, and tuberculosis. Moreover, the
observed association could be due to factors, such as
residential and workplace pollutant exposures [29],
which affect respiratory health and which are more fre-
quent in lower social classes, or could reflect a cumula-
tive life course disadvantage [30]. The high prevalence of
CB among unemployed/retired subjects in 2007/2010
supports the need for public health programs focused on
vulnerable populations. In fact, the relationship between
good health and sustaining employment strengthened
during the last decades due to decreasing employmentTable 4 Adjusted prevalence of CB according to the presence
Ad
ISAYA (1998/2
Asthma* Absent 11.0 [10.5−11
Present 31.2 [29.9−32
Allergic rhinitis* Absent 10.5 [10.2−10
Present 19.9 [19.0−20
* prevalence obtained by stratifying on asthma/allergic rhinitis and adjusted for gen
and centre.
† p-value obtained by testing the null hypothesis that the regression coefficient ofrates and increasing economic inactivity rates among
subjects with poor health [31].
The strength of the association between the presence
of CB and gender has not significantly changed during
the past decade in Italy, and females showed a higher
risk of having CB as compared to males, regardless of
their smoking habits and socio-economic status, and the
coexistence of asthma and allergic rhinitis. A possible
explanation is that females may have more sensitive
cough receptors than males [32]. Moreover, sex hor-
mones may have an effect on airway reactivity [33].
The time trend in the prevalence of CB could have
been influenced by factors other than smoking habits or
socio-economic status, which were not measured in the
present study. In fact, many causes may account for CB,
especially in never smokers. In particular, we were not
able to investigate the association with: i) passive smok-
ing exposure, which is still common and it has been
found to be significantly related to all types of respira-
tory symptoms [34]; ii) occupational exposures to dust,
gas, and fumes over a long period of time, which has
been documented to be a cause of CB [10]; iii) GORD
[17,18], which is due to the fact that the acid reflux con-
sumes the airways or the bronchi and triggers the body
to create increased levels of mucus.
Finally, the exposure to outdoor air pollution was only
investigated in 2007/2010 using a proxy variable of
traffic-related air pollution near home. However, theof asthma and allergic rhinitis
justed prevalence (%) [95% CI]
000) GEIRD (2007/2010) p-value†
.5] 10.7 [9.7−11.8] 0.665
.5] 33.3 [31.5−35.1] 0.144
.9] 9.7 [8.8−10.6] 0.124
.8] 21.2 [20.0−22.5] 0.163
der, age, season of response, type of contact, cumulative response rate,
the dummy indicator of the study (GEIRD vs ISAYA) was zero.
Table 5 Mutually adjusted risk ratios (RRs)* for the association between CB and each potential predictor
RR [95% CI]
ISAYA
(1998/2000)
GEIRD
(2007/2010)
p-value for
heterogeneity†
Gender (female vs male) 1.17 [1.09−1.27] 1.11 [1.00−1.22] 0.721
Smoking habits (vs never smoking):
Past light smoking 1.40 [1.21−1.62] 1.03 [0.86−1.23] 0.015
Past heavy smoking 2.47 [1.96−3.13] 1.66 [1.19−2.31] 0.151
Current light smoking 2.15 [1.95−2.37] 1.95 [1.73−2.19] 0.144
Current heavy smoking 4.82 [4.31−5.39] 3.57 [3.11−4.11] 0.018
Occupational status (unemployed/retired subject vs
employed subject/house-person/student) 1.11 [0.97−1.28] 1.53 [1.31−1.79] 0.019
Asthma (present vs absent) 2.08 [1.84−2.34] 2.01 [1.77−2.30] 0.635
Allergic rhinitis (present vs absent) 1.76 [1.60−1.93] 1.81 [1.63−2.02] 0.680
* RRs also adjusted for age, season of response, type of contact, cumulative response rate, and centre.
† p-value obtained by considering the data from both the studies in the model and by testing the null hypothesis that the regression coefficient of the interaction
term between the covariate and the dummy indicator of the study (GEIRD vs ISAYA) was zero.
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presence of CB supports the evidence that long-term ex-
posure to air pollution is causally associated with re-
spiratory illness [35,36]. In particular, living close to
traffic has been documented to be associated with the
prevalence of CB, which indicates that traffic-related air
pollution has long-term effects on chronic respiratory
disease [9,37]. Thus, in addition to the relatively rare
episodes of incidental, heavy air pollution, the common
levels of exposure to air pollutants may increase the
prevalence of CB and other respiratory diseases.CB, asthma, and allergic rhinitis
The prevalence of asthma and allergic rhinitis increased
in the last ten years in Italy, as already reported in a pre-
vious analysis of the ISAYA and GEIRD data [19]. Pro-
posed contributing factors to the increase in the
prevalence of asthma are the exposure to air pollution,
infections, microbial substances in the environment, and
obesity [38], whereas the upward trend in the prevalence
of allergic rhinitis could be due to increasing air pollu-
tion, indoor environmental factors, improved hygiene
practices, geo-climatic factors, or all of the above [19].
Despite the positive trend in their prevalence, the
strength of the association with the presence of CB did
not change for both asthma and allergic rhinitis, and our
estimates are comparable to the results obtained in 16
industrialized countries in the ECRHS [17]. As already
reported, the association between asthma and CB identi-
fies a subgroup of patients characterized by frequent
exacerbations, inadequate treatment, or poor disease
control [11,12], which result in a heavy socio-economic
burden [13-15]. Alternatively, it may be a result of the
coexistence of asthma with COPD [16].In agreement with previous studies [17,39], CB was
highly prevalent among subjects with allergic rhinitis.
This association confirms that post-nasal drip is a fre-
quent cause of cough, which could also contribute to the
volume of sputum expectoration. In particular, allergic
rhinitis is a risk factor for sinusitis [40], which is highly
prevalent in the general Italian population [41] and is a
cause of post-nasal drip. However, especially in this case,
CB may be multifactorial because many patients with
asthma have rhinitis and, in turn, many patients with
rhinitis have asthma or are at risk of asthma [42,43].
Strengths and weaknesses of the study
The temporal change in CB is likely to reflect the trend
in the prevalence rather than differences in the study de-
sign or changes in health care practice. In fact, our
results were obtained by analyzing the data from two
large surveys, which were carried out in the general
population by using the same design, sampling frame,
and protocol. Moreover, our estimates are based on self-
reported symptoms, which were collected throughout
international validated questionnaires [23] and are less
influenced by diagnostic procedures.
A few caveats should be taken into account when
interpreting our results. The Italian centres participating
in ISAYA or GEIRD were not chosen randomly, but on
the availability of research teams that were able to carry
out the survey, and only a sub-sample of the Italian cen-
tres (Pavia, Sassari, Turin, Verona) was involved in both
the surveys. However, despite this non-random selection,
the study centres are located all over Italy and are repre-
sentative of the geographical and climatic features of the
country. Moreover, the sensitivity analysis carried out by
considering only these four centres gave the same results
as that obtained in the main analysis.
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2000 to 57.2% in 2007/2010, as observed in other epi-
demiological studies over the past decades [44], and this
decrease may have biased our estimates. In fact, symptom
prevalence may be overestimated in GEIRD if the willing-
ness to respond to the questionnaire is related to respira-
tory health [45]. However, it has been suggested that
declines in participation rates are not likely to have a sub-
stantial influence on the exposure-disease associations or
on the point estimates of measures of interest [44].
Conclusions
Despite the significant reduction in current smoking, the
prevalence of CB did not vary during the past decade
among young adults in Italy. The temporal pattern in
the prevalence of CB can only be partly explained by the
increase in the prevalence of unemployment/premature
retirement, asthma, and allergic rhinitis in the same
period, and suggests that other factors could have played
a role.
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between CB and each potential predictor. The RRs were obtained by
considering only the data from the four centres (Pavia, Sassari, Turin,
Verona) that had participated in both the surveys.
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